Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2005

View Archived Issues

Methylene blue increases brain oxygen consumption and facilitates memory retention in rats

Neuroprotective effects of S-34176, a free radical scavenger

Chronic gamma-secretase blockade safe and beneficial in experimental AD / News in Context

TheraQuest pain drug candidates investigated in preclinical, clinical studies

(-)-BPAP HCl neuroprotective in organotypic slice cultures

A phase III trial finds no efficacy for edifoligide in the prevention of CABG failure

NuvaRing reported as effective as an oral combination of contraceptives

Clinical evidence supports the use of laquinimod in multiple sclerosis

Gaboxadol shows promise in the treatment of insomnia in elderly subjects

Studies reveal therapeutic value of pregabalin in treating neuropathic pain

ALGRX-4975 reduces pain in osteoarthritis, bunionectomy

Orphan medicinal product status for TGN-1412 in Europe

Maruho and Toray Industries to jointly develop TRK-820 in Japan

Topical anesthesia with ALGRX-3268 tested in children undergoing venipuncture

Keppra effective in adjunctive treatment of myoclonic seizures

Sativex improves pain and symptoms in multiple sclerosis

Serono licenses Syntonix' technologies to develop inhalable interferon-beta:Fc

New patents disclose therapeutic agents for cancer

Novel immunomodulatory agents disclosed by CNRS and INSERM

Recent patents describe new antiinfective compounds

Past Tysabri patient had PML

ImmunoGen submits IND for huC242-DM4

Aeras and Statens Serum Institut team up on TB vaccine development

Enrollment completed in U.S. Fluviral study

ExCel study to investigate ability of exemestane to prevent breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...